Diagnostic Biosystems is leading developer of high quality immunohistochemistry reagents, producing novel, clinically relevant tools for the pathology market.
Location: United States, California, Pleasanton
Employees: 11-50
Phone: +1 925-484-3350
Founded date: 1994
Investors 1
| Date | Name | Website |
| - | BroadOak C... | broadoak.c... |
Mentions in press and media 4
| Date | Title | Description |
| 02.09.2022 | Diagnostic BioSystems (DBS) collaborates with VWR | Together We Reach More Labs Efficiently in North America CA, PLEASANTON, USA, September 2, 2022 /EINPresswire.com/ -- Diagnostic BioSystems (DBS) partners with VWR, part of Avantor, to deliver histopathology product line in the CE IVD and R... |
| 29.06.2022 | DIAGNOSTIC BIOSYSTEMS INC. (USA) PARTNERS WITH LEADER LIFE SCIENCES (UAE) TO PROVIDE ADVANCED IHC SOLUTIONS IN UAE | PARTNERS WITH LEADER LIFE SCIENCES PLEASANTON, CA, USA, June 28, 2022 /EINPresswire.com/ -- Diagnostic Biosystems (DBS) Inc, USA, a Global provider of cutting-edge in vitro diagnostics and high-quality immunohistochemistry (IHC) solutions c... |
| 27.06.2022 | Diagnostic BioSystems Inc. partners with ESBE Scientific Industries Inc. to provide IHC solutions to the Canadian Market | Diagnostic BioSystems Inc. partners with the ESBE Scientific Industries MARKHAM, ONTARIO, CANADA, June 26, 2022 /EINPresswire.com/ -- In an effort to cater to the Canadian histopathology research laboratories, the Canadian CRO’s and the gro... |
| 11.05.2015 | Diagnostic BioSystems Completes Growth Capital Financing with BroadOak Capital Partners | Diagnostic BioSystems, a Pleasanton, CA-based developer of immunohistochemistry (IHC) solutions in the life science research and anatomic pathology markets, completed a growth capital financing with BroadOak Capital Partners, a life science... |